Serum Institute of India

Monthly production capacity of Covishield 11 cr doses, Covaxin 2.5 cr doses: Centre

Monthly production capacity of Covishield 11 cr doses, Covaxin 2.5 cr doses: Centre

New Delhi The current average monthly production capacity of Covishield by Serum Institute of India is 11 crore doses and of Covaxin by B...Read More

Serum Institute produced 110 million Covishield vaccines till July: Report

Serum Institute produced 110 million Covishield vaccines till July: Report

According to a report by NDTV, Serum Institute of India (SII) has ramped up its production of Covishield vaccine up to around 110 million...Read More

'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for children

'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for children

New Delhi: An expert panel constituted by the government has recommended against granting permission to Serum Institute of India (SII) to...Read More

Govt panel recommends against allowing Serum Institute to conduct trial of Covovax on children aged 2-17 years

Govt panel recommends against allowing Serum Institute to conduct trial of Covovax on children aged 2-17 years

New Delhi: An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Inst...Read More

Confident of getting EMA's approval in a month for Covishield: Serum Insitute CEO Adar Poonawalla

Confident of getting EMA's approval in a month for Covishield: Serum Insitute CEO Adar Poonawalla

Vaccine major Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vacci...Read More

COVID-19: Serum Institute of India begins manufacturing of first batch of Covovax

COVID-19: Serum Institute of India begins manufacturing of first batch of Covovax

The Serum Institute of India (SII) on Friday announced the commencement of manufacturing of the first batch of Covovax vaccine at the Pun...Read More

Serum Institute of India seeks DCGI's nod to manufacture Sputnik V

Serum Institute of India seeks DCGI's nod to manufacture Sputnik V

Russia's Sputnik V vaccine is currently being manufactured by Dr Reddy's Laboratories in India

Higher functionary from state must assure protection to Serum Institute CEO Adar Poonawalla: Bombay HC tells Maharashtra govt

Higher functionary from state must assure protection to Serum Institute CEO Adar Poonawalla: Bombay HC tells Maharashtra govt

The Bombay High Court bench of Justices Sambhaji Shinde and Ajay Ahuja on Tuesday expressed concern regarding the protection of Adar Poon...Read More

Magma Fincorp gets new top management: Adar Poonawalla chairman and Vijay Deshwal CEO

Magma Fincorp gets new top management: Adar Poonawalla chairman and Vijay Deshwal CEO

The Poonawala Group on Monday announced a new management structure for Magma Fincorp, which it had taken over for Rs 3,456 crore, appoint...Read More

Serum Institute CEO promises to deliver 1.5 crore Covishield doses to Maharashtra after May 20, says Rajesh Tope

Serum Institute CEO promises to deliver 1.5 crore Covishield doses to Maharashtra after May 20, says Rajesh Tope

Serum Institute of India CEO Adar Poonawalla has promised Chief Minister Uddhav Thackeray to deliver 1.5 crore doses of COVID-19 vaccine ...Read More

Serum Institute of India to invest 240 mn pounds in UK; create around 6,500 jobs

Serum Institute of India to invest 240 mn pounds in UK; create around 6,500 jobs

The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating ...Read More

‘India may face shortage of COVID-19 vaccines till July,’ says Adar Poonawalla

‘India may face shortage of COVID-19 vaccines till July,’ says Adar Poonawalla

Adar Poonawalla, chief executive officer, Serum Institute of India (SII), said India may face shortage of vaccines for the next few month...Read More

Maharashtra govt writes to SII, Bharat Biotech about their demand of COVID-19 vaccines

Maharashtra govt writes to SII, Bharat Biotech about their demand of COVID-19 vaccines

The Maharashtra government has written to COVID-19 vaccine manufacturers Serum Institute of India (SII) and Bharat Biotech about the stat...Read More

Maharashtra may get supply of Covishield only after May 20: Rajesh Tope

Maharashtra may get supply of Covishield only after May 20: Rajesh Tope

Maharashtra Health Minister Rajesh Tope on Tuesday said the state may receive its supply of 'Covishield' vaccine only after May 20. Talki...Read More

'Wash your mouths': Farhan Akhtar's befitting reply to those who trolled him for questioning vaccine price

'Wash your mouths': Farhan Akhtar's befitting reply to those who trolled him for questioning vaccine price

The government asked SII and Bharat Biotech to lower the price of COVID vaccines as India gears up to inoculate all aged above 18

SII CEO Adar Poonawalla has assured 'maximum support' to Maharashtra in scaling up vaccination: Uddhav Thackeray's Office

SII CEO Adar Poonawalla has assured 'maximum support' to Maharashtra in scaling up vaccination: Uddhav Thackeray's Office

Serum Institute of India (SII) CEO Adar Poonawalla has assured Maharashtra Chief Minister Uddhav Thackeray of support to ensure maximum v...Read More

Covisheld is the most affordable Covid-19 vaccine available: Serum Institute of India defends vaccine pricing

Covisheld is the most affordable Covid-19 vaccine available: Serum Institute of India defends vaccine pricing

Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a ...Read More

'Incorrect facts': Serum Institute of India refutes reports of contracting all its production till May 25 to Centre only

'Incorrect facts': Serum Institute of India refutes reports of contracting all its production till May 25 to Centre only

Issuing a statement, the SII said, these reports are based on incorrect facts and are without any basis

Bombay HC dismisses plea to restrict SII’s Covishield trademark use

Bombay HC dismisses plea to restrict SII’s Covishield trademark use

Mumbai: A division bench of Justices Nitin Jamdar and Chandrakant Bhadang of the Bombay High Court dismissed a plea from a Nanded-based p...Read More

Centre approves Rs 4,500 cr credit to COVID-19 vaccine makers Serum Institute of India, Bharat Biotech to ramp up production

Centre approves Rs 4,500 cr credit to COVID-19 vaccine makers Serum Institute of India, Bharat Biotech to ramp up production

The Ministry of Finance on Monday approved to sanction supply credit to India's COVID-19 vaccine manufacturers Serum Institute of India a...Read More

Free Press Journal

www.freepressjournal.in